SAREPTA THERAPEUTICS, INC. (SRPT) Operating income 2016–2025
SAREPTA THERAPEUTICS, INC. (SRPT) annual operating income history from SEC filings — each fiscal year as reported.
-$699.8MFY2025 · since FY2016: -$266.7M → -$699.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$699.8M | -420.9% |
| FY2024 | $218.1M | +181.4% |
| FY2023 | -$267.8M | +50.1% |
| FY2022 | -$536.2M | -16.6% |
| FY2021 | -$459.7M | +18.5% |
| FY2020 | -$564.2M | +20.0% |
| FY2019 | -$705.6M | -105.3% |
| FY2018 | -$343.6M | -100.2% |
| FY2017 | -$171.6M | +35.7% |
| FY2016 | -$266.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SRPT financial trends
SRPT RevenueSRPT Net incomeSRPT Net marginSRPT Gross profitSRPT Gross marginSRPT Operating marginSRPT Operating cash flowSRPT Free cash flowSRPT Capital expendituresSRPT Return on equitySRPT Stock buybacksSRPT Dividends paidSRPT Total assetsSRPT Total liabilitiesSRPT Shareholders’ equitySRPT overview →